CRANBURY, N.J., Oct. 27, 2011 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD), a biopharmaceutical company at the forefront of developing therapies for rare diseases, today announced a conference call and live audio webcast on Tuesday, November 1, 2011 at 5 p.m. ET to discuss financial results for the third quarter ended September 30, 2011.
The call will be hosted by John F. Crowley, Chairman and Chief Executive Officer. He will be joined on the call by additional members of the Amicus management team.
Date: November 1, 2011
Time: 5:00 PM ET
Listen via Internet: http://ir.amicustherapeutics.com/
Schedule this webcast into MS-Outlook calendar (click open when prompted): http://apps.shareholder.com/PNWOutlook/t.aspx?m=50379&k=1913619F
Toll-free: 877-303-5859 (U.S./Canada)
International: 678-224-7784
Web participants are encouraged to go to the Investors section of the Amicus Therapeutics corporate web site 15 minutes prior to the start of the call to register, download and install any necessary software. The audio webcast will be archived for 30 days.
A telephonic replay of the call will be available for seven days beginning at 8 p.m. ET on November 1, 2011. Access numbers for this replay are 855-859-2056 (U.S./Canada) and 404-537-3406 (international); participant code 22660442.
About Amicus Therapeutics
Amicus Therapeutics (Nasdaq:FOLD) is a biopharmaceutical company at the forefront of developing therapies for rare diseases. The Company is developing orally-administered, small molecule drugs called pharmacological chaperones, a novel, first-in-class approach to treating a broad range of diseases including lysosomal storage disorders and diseases of neurodegeneration. Amicus' lead program Amigal™ (migalastat HCl) is in Phase 3 for the treatment of Fabry disease.